Beck Bode LLC’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Buy
5,018
+31
+0.6% +$1.51K 0.04% 88
2026
Q1
$214K Sell
4,987
-402
-7% -$17.3K 0.04% 88
2025
Q4
$236K Sell
5,389
-215
-4% -$8.89K 0.04% 89
2025
Q3
$231K Buy
+5,604
New +$225K 0.04% 89

Other funds holding EXEL

Beck Bode LLC's EXEL Position: Q2 2026 in Review

Beck Bode LLC increased its Exelixis (EXEL) stake by 0.62% in Q2 2026, buying an estimated $1.51K and bringing the position to 5,018 shares worth $273K. The position accounts for 0.04% of the portfolio, ranked #88.

Beck Bode LLC first reported a position in EXEL in Q3 2025 and has held it in 4 quarters since. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Beck Bode LLC held 5,018 shares of Exelixis worth $273K as of Q2 2026.
  • Beck Bode LLC bought 31 Exelixis shares in Q2 2026, an estimated $1.51K.
  • Exelixis made up 0.04% of Beck Bode LLC's portfolio in Q2 2026, its #88 holding.
  • Beck Bode LLC first reported a position in Exelixis in Q3 2025 and has held it in 4 quarters since.
  • 756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Beck Bode LLC's 13F filing for Q2 2026, filed 13 Aug 2026.